Primary |
Pain |
83.3% |
Product Used For Unknown Indication |
16.7% |
|
Miosis |
25.0% |
Overdose |
25.0% |
Rash |
25.0% |
Vomiting |
25.0% |
|
Secondary |
Product Used For Unknown Indication |
76.9% |
Ill-defined Disorder |
6.8% |
Pain |
3.7% |
Completed Suicide |
2.6% |
Nosocomial Infection |
2.4% |
Pain In Extremity |
1.3% |
Renal Pain |
0.9% |
Back Pain |
0.7% |
Chronic Obstructive Pulmonary Disease |
0.7% |
Neuralgia |
0.7% |
Plasma Cell Myeloma |
0.7% |
Anxiety |
0.4% |
Drug Use For Unknown Indication |
0.4% |
Neuropathy Peripheral |
0.4% |
Sciatica |
0.4% |
Abdominal Discomfort |
0.2% |
Anorexia |
0.2% |
Blood Pressure Abnormal |
0.2% |
Chronic Myeloid Leukaemia |
0.2% |
Headache |
0.2% |
|
Toxicity To Various Agents |
53.8% |
Drug Abuse |
11.5% |
Respiratory Arrest |
8.3% |
Intentional Drug Misuse |
4.5% |
Cardiac Arrest |
1.9% |
Cardio-respiratory Arrest |
1.9% |
Somnolence |
1.9% |
Tremor |
1.9% |
Vomiting |
1.9% |
Completed Suicide |
1.3% |
Exposure Via Ingestion |
1.3% |
Mesothelioma |
1.3% |
Pain In Extremity |
1.3% |
Respiratory Disorder |
1.3% |
Thrombosis |
1.3% |
Unresponsive To Stimuli |
1.3% |
Vision Blurred |
1.3% |
Convulsion |
0.6% |
Death |
0.6% |
Depression |
0.6% |
|
Concomitant |
Plasma Cell Myeloma |
18.3% |
Ill-defined Disorder |
14.8% |
Chronic Myeloid Leukaemia |
7.1% |
Multiple Myeloma |
6.8% |
Multiple Sclerosis |
5.5% |
Pain |
4.5% |
Depression |
4.2% |
Neoplasm Malignant |
4.2% |
Non-small Cell Lung Cancer |
4.2% |
Product Used For Unknown Indication |
4.2% |
Chronic Lymphocytic Leukaemia |
3.5% |
Osteoporosis |
3.5% |
Prostate Cancer Metastatic |
3.2% |
Acute Myeloid Leukaemia |
2.6% |
Hepatitis C |
2.3% |
Neuralgia |
2.3% |
Neuropathy |
2.3% |
Pancreatic Carcinoma |
2.3% |
Renal Cell Carcinoma Stage Unspecified |
2.3% |
Type 2 Diabetes Mellitus |
2.3% |
|
Vomiting |
12.2% |
Weight Decreased |
10.1% |
Rash |
6.8% |
Pyrexia |
6.1% |
Weight Increased |
6.1% |
White Blood Cell Count Decreased |
6.1% |
Urinary Tract Infection |
5.4% |
Pneumonia |
4.7% |
Tremor |
4.7% |
Vision Blurred |
4.7% |
Sickle Cell Anaemia With Crisis |
4.1% |
Drug Ineffective |
3.4% |
Dyspnoea |
3.4% |
Mesothelioma |
3.4% |
Nausea |
3.4% |
Platelet Count Decreased |
3.4% |
Tachycardia |
3.4% |
White Blood Cell Count Increased |
3.4% |
Muscle Spasms |
2.7% |
Pain |
2.7% |
|